Literature DB >> 7242225

Basic nerve function assessment in leprosy patients.

W Brandsma.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7242225     DOI： 10.5935/0305-7518.19810019

Source DB:  PubMed          Journal:  Lepr Rev        ISSN： 0305-7518            Impact factor:   0.537


× No keyword cloud information.
  4 in total

1.  High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy.

Authors:  R Manandhar; N Shrestha; C R Butlin; P W Roche
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  High-resolution sonography: a new technique to detect nerve damage in leprosy.

Authors:  Suman Jain; Leo H Visser; T L N Praveen; P Narasimha Rao; Thummalakunta Surekha; Ramesh Ellanti; Thummalakunta L N Abhishek; Indira Nath
Journal:  PLoS Negl Trop Dis       Date:  2009-08-11

3.  Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1).

Authors:  W Cairns S Smith; Alison M Anderson; Stephen G Withington; Wim H van Brakel; Richard P Croft; Peter G Nicholls; Jan Hendrik Richardus
Journal:  BMJ       Date:  2004-05-24

4.  Two randomized controlled clinical trials to study the effectiveness of prednisolone treatment in preventing and restoring clinical nerve function loss in leprosy: the TENLEP study protocols.

Authors:  Inge Wagenaar; Wim Brandsma; Erik Post; Wim van Brakel; Diana Lockwood; Peter Nicholls; Paul Saunderson; Cairns Smith; Einar Wilder-Smith; Jan Hendrik Richardus
Journal:  BMC Neurol       Date:  2012-12-18       Impact factor: 2.474
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.